Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesStocksEarnInstitutionAI & More
DFI Retail's Share-Price Weakness Likely Doesn't Reflect Company-Specific Issues -- Market Talk

DFI Retail's Share-Price Weakness Likely Doesn't Reflect Company-Specific Issues -- Market Talk

Dow JonesDow Jones2026/10/26 03:53

0353 GMT - DFI Retail's year-to-date share-price weakness likely reflects broader market flows away from consumer discretionary names rather than company-specific issues, say CGS International analysts in a note. Shares of the retailer, which operates brands such as 7-Eleven in certain Asian markets, are 15% lower year-to-date. The market has likely largely absorbed an expected 2027 earnings dilution from DFI divesting its stake in Maxim's while acquiring Starbucks, the analysts say. The analysts are confident DFI would be able to deliver its full-year underlying profit target of US$295 million-US$305 million. CGSI retains its add rating and US$5.50 target price on the company's Singapore-listed stock, which rises 0.9% to US$3.36.(megan.cheah@wsj.com)

(END) Dow Jones Newswires

October 25, 2026 23:53 ET (03:53 GMT)

0
0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!

You may also like

AbbVie (ABBV.US) expands Oxford R&D facility in UK, betting on innovation in immunology, neuroscience, and oncology drugs

AbbVie announced on Wednesday that, as part of an investment plan exceeding 120 million pounds (approximately $161 million), the company has expanded its research and development facility in Oxford, United Kingdom.

智通财经•2026/11/04 02:51

BNB fell below $690

金色财经•2026/11/04 02:37
BNB fell below $690